Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer

Figure 2

Increasing expression of immunoinhibitors was observed in PC samples. TGFB1 (a), PVRL2 (b), CSF1R (c), TGFBR1 (d), VTCN1 (e), LGALS9 (f), IL10RB (g), KDR (h), and IDO1 (i) mRNA levels were significantly upregulated in patients with PC compared to normal tissues.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)